Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 277-551-0 | CAS number: 73609-36-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
There are no data on the toxicokinetics of [2-(perfluorohexyl)ethyl]dichloro(methyl)silane.
The following summary has therefore been prepared based on predicted and measured physicochemical properties of the substance itself and its hydrolysis products. The data have been used in algorithms which are the basis of many computer-based physiologically based pharmacokinetic or toxicokinetic (PBTK) prediction models. Although these algorithms provide quantitative outputs, for the purposes of this summary only qualitative statements or predictions will be madebecause of the remaining uncertainties that are characteristic of prediction models.
The main input variable for the majority of these algorithms is log Kowso by using this and, where appropriate, other known or predicted physicochemical properties of[2-(perfluorohexyl)ethyl]trichlorosilaneor its hydrolysis products, reasonable predictions or statements may be made about their potential absorption, distribution, metabolism and excretion (ADME) properties.
[2-(perfluorohexyl)ethyl]dichloro(methyl)silane is a moisture-sensitive liquid that hydrolyses very rapidly in contact with water(based on read-across from related substances: half-life approximately 5 seconds at 25°C and pH 4, 7 and 9), generating [2-(perfluorohexyl)ethyl]silanediol and hydrogen chloride. Human exposure could occur via the inhalation or dermal routes. Relevant inhalation exposure would be to the hydrolysis products (hydrolysis would occur rapidly when inhaled, even if a mixture of parent and hydrolysis products were present in air). The substance would also hydrolyse rapidly in contact with moist skin. The resulting hydrogen chloride hydrolysis product would be severely irritating or corrosive.
Potential systemic exposure to hydrogen chloride is not discussed.
Absorption
Oral
Significant oral exposure is not expected for the corrosive parent substance, [2‑(perfluorohexyl)ethyl]trichlorosilane.However, oral exposure to humans via the environment may be relevant for the hydrolysis product[2-(perfluorohexyl)ethyl]silanediol.
When oral exposure takes place it can be assumed, except for the most extreme of insoluble substances, that uptake through intestinal walls into the blood occurs. Uptake from the intestines can be assumed to be possible for all substances that have appreciable solubility in water or lipid. Other mechanisms by which substances can be absorbed in the gastrointestinal tract include the passage of small water-soluble molecules (molecular weight up to around 200) through aqueous pores or carriage of such molecules across membranes with the bulk passage of water (Renwick, 1993).
The hydrolysis product [2-(perfluorohexyl)ethyl]silanediol has a low predicted water solubility of 0.0048 mg/l at 20°C (QSAR) and a molecular weight (424.2) which is above the favourable range, therefore it is considered that significant systemic exposure to the hydrolysis product following oral exposure is unlikely.However, the surface active properties of [2-(perfluorohexyl)ethyl]silanediol mean that the predictions are not be reliable for this substance. Some systemic effects were reported in the available acute oral toxicity study (OECD 423). Since [2-(perfluorohexyl)ethyl]dichloro(methyl)silane is hydrolytically unstable, it is considered that the animals would have been exposed to the hydrolysis products, [2-(perfluorohexyl)ethyl]methylsilanediol and hydrochloric acid, and that the effects observed reflect the properties of the hydrolysis products. Therefore, the study indicates that absorption following oral exposure does occur.
Dermal
The fat solubility and therefore potential dermal penetration of a substance can be estimated by using the water solubility and log Kowvalues. Substances with log Kowvalues between 1 and 4 favour dermal absorption (values between 2 and 3 are optimal) particularly if water solubility is high. The predicted water solubility (0.0048 mg/l) of [2-(perfluorohexyl)ethyl]silanediol is unfavourable for absorption across the skin and the log Kowof 4.6 is above the favourable range. Therefore dermal absorption is unlikely to occur, since the substance is not sufficiently soluble in water to partition from the stratum corneum into the epidermis. However, since[2-(perfluorohexyl)ethyl]dichloro(methyl)silane is corrosive to the skin,dermal absorption could be increased if damage to the skin occurs due to corrosive effects of the substance. As for the oral route of exposure these predictions might not be suitable due to the surface active properties of the parent substance.There are no dermal studies to check for signs of systemic availability.
Inhalation
There is a Quantitative Structure-Property Relationship (QSPR) to estimate the blood:air partition coefficient for human subjects as published by Meulenberg and Vijverberg (2000). The resulting algorithm uses the dimensionless Henry coefficient and the octanol:air partition coefficient (Koct:air) as independent variables.
Using these values for [2-(perfluorohexyl)ethyl]silanediol results in a blood:air partition coefficient of approximately 0.04:1 meaning that if lung exposure occurred uptake into the circulatory system would be unlikely. The low water solubility of [2-(perfluorohexyl)ethyl]silanediol also suggests that it is unlikely be dissolved in the mucous of the respiratory tract lining, so passive absorption from the mucous is unlikely.
As with dermal exposure, damage to membranes caused by the corrosive nature of the hydrogen chloride hydrolysis product may increase the uptake. There are no inhalation studies to check for signs of systemic availability.
Distribution
For blood:tissue partitioning a QSPR algorithm has been developed by DeJongh et al. (1997) in which the distribution of compounds between blood and human body tissues as a function of water and lipid content of tissues and the n-octanol:water partition coefficient (Kow) is described. Using this value for[2-(perfluorohexyl)ethyl]silanediolpredicts that, should systemic exposure occur, potential distribution into the main body compartments would be predominately to the fat.
Table 1: Tissue:blood partition coefficients
|
Log Kow |
Kow |
Liver |
Muscle |
Fat |
Brain |
Kidney |
[2-(perfluorohexyl)ethyl]silanediol |
4.6 |
39810 |
8.7 |
5.4 |
113.6 |
11.3 |
6.5 |
Metabolism
[2-(perfluorohexyl)ethyl]dichloro(methyl)silane is rapidly hydrolysed in the presence of moisture to [2‑(perfluorohexyl)ethyl]silanediol and hydrogen chloride. Most if not all of this will have occurred before absorption into the body. Genetic toxicity testsin vitrowith the registered substance [2-(perfluorohexyl)ethyl]dichloro(methyl)silane showed no observable differences in effects with and without metabolic activation.
Excretion
A determinant of the extent of urinary excretion is the soluble fraction in blood. QPSRs as developed by DeJongh et al. (1997) using log Kowas an input parameter, calculate the solubility in blood based on lipid fractions in the blood assuming that human blood contains 0.7% lipids.
Using the algorithm, the soluble fraction of [2-(perfluorohexyl)ethyl]silanediol in blood is <1% and the substance is therefore unlikely to be eliminated via the kidneys in urine.
Renwick A. G. (1993) Data-derived safety factors for the evaluation of food additives and environmental contaminants.Fd. Addit. Contam.10: 275-305.
Meulenberg, C.J. and H.P. Vijverberg, Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. Toxicol Appl Pharmacol, 2000. 165(3): p. 206-16.
DeJongh, J., H.J. Verhaar, and J.L. Hermens, A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch Toxicol, 1997.72(1): p. 17-25.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.